Close Menu

NEW YORK (GenomeWeb) – Group K Diagnostics said today that it has inked an agreement with the US Centers for Disease Control and Prevention to design and evaluate a prototype reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) assay for the detection of Zika virus (ZIKV) RNA at the point of care.

The device is being developed for use by healthcare practitioners in resource-limited areas where real-time RT-PCR instrumentation is not available, Group K said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.